Latest news articles

Added 1 month ago Drug news

CHMP recommends a label variation to Neulasta to include the Neulasta Onpro Kit.- Amgen.

Amgen has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Added 2 months ago Drug news

Rolontis is non inferior to pegfilgrastim for mamagement of severe chemotherapy- induced neutropenia.- Spectrum Pharma

Spectrum Pharmaceuticals, Inc. announced that the first Phase III study of Rolontis (eflapegrastim), ADVANCE, has met its primary endpoint of...

Added 3 months ago Drug news

Phase III trial of F 627 meets primary endpoint in chemotherapy-induced neutropenia.- Generon.

Generon Corporation announced that the first pivotal phase III study in the U.S. for F 627 to treat chemotherapy-induced neutropenia...

Search all news articles for Diseases of white blood cells
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Psoriasis

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more.

+ 2 more

Inflammatory Bowel Disease Knowledge Centre

Inflammatory Bowel Disease Knowledge Centre

The Inflammatory Bowel Disease (IBD) Knowledge Centre contains key information relating to the epidemiology and pathophysiology of Crohn’s disease and ulcerative colitis, highlighting prevalence, impact and unmet needs and the underlying inflammatory processes that drive IBD, considering some of the key inflammatory pathways.

Load more

Guidelines

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

Febrile neutropaenia is the development of fever, often with other signs of infection, in a patient with neutropaenia, an abnormally low number of neutrophil granulocytes in the blood.

Added 8 years ago

Neutropenic sepsis: prevention and management in people with cancer

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Mortality rates ranging between 2% and 21% have...

Added 5 years ago

Search all guidelines for Diseases of white blood cells
 

Journal articles

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.

Ascertainment of cases and disease classification is an acknowledged problem for epidemiological research into haematological malignancies.

Added 7 months ago

Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial.

Background: Hypomethylating drugs are the standard treatment for patients with high-risk myelodysplastic syndromes. Survival is poor after failure of these...

Added 2 years ago

Search all journal articles for Diseases of white blood cells